Classification of Patients with Relapsing Polychondritis Based on Somatic Mutations in UBA1 Marcela Ferrada, MD – National Institutes of Health
3:10 PM – 3:20 PM ET
Expression and Functional Activity of the Angiotensin II System in Temporal Artery Lesions from Patients with Giant Cell Arteritis Marco A Alba, MD, PhD – IDIBAPS
3:20 PM – 3:30 PM ET
ERAP1-mediated Immunogenicity and Immune-phenotypes in HLA-B51+ Behçet’s Disease Point to Pathogenic CD8 T Cell Effector Responses Johannes Nowatzky, MD – New York University School of Medicine
3:30 PM – 3:40 PM ET
Efficacy of Apremilast for the Treatment of Manifestations of Behçet’s Syndrome Other Than Oral Ulcers, Including Skin Lesions and Arthritis Gülen Hatemi, MD – Istanbul University Cerrahpasa Medical Faculty
3:40 PM – 3:50 PM ET
Mass Spectrometry Identifies Novel Biomarkers in Giant Cell Arteritis, Useful in Patients on Interleukin-6 Receptor Blockade Sebastian Unizony, MD – Massachusetts General Hospital
.png "Tanaz Kermani, MD photo")
